fbpx
April 30, 2021

CBD’s Role in Acute Pain Relief Tied to Patient Expectations CBD’s Role in Acute Pain Relief Tied to Patient Expectations

The pain-relieving effects of cannabidiol (CBD) may be linked to its influence on affective processes, new research shows. In a pilot study, investigators from the University […]
April 29, 2021

AHA Guidance on Blood Clots Linked to COVID-19 Vaccine AHA Guidance on Blood Clots Linked to COVID-19 Vaccine

A newly released report is offering guidance concerning rare conditions associated with COVID-19 as well as vaccines against the virus. The report was released today by […]
April 29, 2021

Some MS Treatments May Heighten COVID Risk Some MS Treatments May Heighten COVID Risk

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. When it comes to SARS-CoV-2 infection among patients with multiple sclerosis (MS), […]
April 28, 2021

Vagus Nerve Stimulation, Rehab Effective After Stroke Vagus Nerve Stimulation, Rehab Effective After Stroke

Vagus nerve stimulation (VNS) paired with intensive rehabilitation for moderate to severe arm weakness months or even years after stroke may lead to a greater improvement […]
April 28, 2021

Doctors More Likely to Prescribe Opioids to COVID ‘Long Haulers,’ Raising Addiction Fears Doctors More Likely to Prescribe Opioids to COVID ‘Long Haulers,’ Raising Addiction Fears

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Covid survivors are at risk from a separate epidemic of opioid addiction, […]
April 26, 2021

A New Biomarker of Traumatic Brain Injury? A New Biomarker of Traumatic Brain Injury?

Plasma levels of von Willebrand factor may be a useful biomarker of traumatic brain injury (TBI) and its severity, new research suggests. “Reliable detection of this […]
April 26, 2021

Investigational Drug Reduces Brain Lesions in Highly Active MS Investigational Drug Reduces Brain Lesions in Highly Active MS

The investigational drug tolebrutinib effectively reduces brain lesions in patients with highly active relapsing-remitting multiple sclerosis (RRMS), new research suggests. After 12 weeks of treatment, MRI […]
April 23, 2021

Evobrutinib May Help Reduce MS Nerve Damage Evobrutinib May Help Reduce MS Nerve Damage

Oral evobrutinib, an investigational highly selective Bruton’s tyrosine kinase inhibitor, may have a beneficial effect on reducing nerve damage in multiple sclerosis (MS), based on how it’s […]
April 23, 2021

FDA Clears Brain-Computer Interface Device to Aid Stroke Rehab FDA Clears Brain-Computer Interface Device to Aid Stroke Rehab

The US Food and Drug Administration (FDA) has approved the IpsiHand Upper Extremity Rehabilitation System (IpsiHand System), a noninvasive device that uses a brain-computer interface to […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0